ArticleResearch and practice in thrombosis and haemostasis2022
The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description.
Article in Research and practice in thrombosis and haemostasis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 19 citations in OpenAlex.
- Time Trends in Cause-Specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older.Thrombosis and haemostasis · 2026Article
- The impact of symptom duration on D-dimer: results from the Venous Thrombosis Registry in Østfold Hospital.Research and practice in thrombosis and haemostasis · 2026Article
- Item generation for a new disease-specific health-related quality of life questionnaire in patients with deep vein thrombosis: an international multicenter study.Research and practice in thrombosis and haemostasis · 2026Article
- Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry.TH open : companion journal to thrombosis and haemostasis · 2026Article
- Predictive modeling for mortality risk in elderly patients with pulmonary embolism using machine learning algorithms.Frontiers in medicine · 2026Article
- Temporal trend in venous thromboembolism hospitalization rates in Brazil.Revista da Associacao Medica Brasileira (1992) · 2025Article
- Current Role of CT Pulmonary Angiography in Pulmonary Embolism: A State-of-the-Art Review.Journal of imaging · 2024Review
- Lessons learned from setting up a hospital-based national registry for venous thromboembolic disorders in India.Journal of family medicine and primary care · 2024Article
- Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study.Research and practice in thrombosis and haemostasis · 2024Article
- Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry.TH open : companion journal to thrombosis and haemostasis · 2024Article
- The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description.Research and practice in thrombosis and haemostasis · 2022Article
- Incidence and Clinical Features of Venous Thromboembolism in Inpatients with Mental Illness.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The incidence of venous thromboembolism (VTE) is expected to increase over the next decades, further increasing its substantial impact on patients and health care resources. Registries have the benefit of reporting real-world data without excluding clinically important subgroups. Our aim was to describe a Norwegian VTE registry and to provide descriptive data on the population and management. Registry Population: The Venous Thrombosis Registry in Østfold Hospital (TROLL) is an ongoing registry of consecutive patients diagnosed with, treated, and/or followed up for VTE at Østfold Hospital, Norway, since 2005. Baseline and follow-up data, including demographics, clinical features, risk factors, diagnostic procedures, classification of VTE, and treatment were collected during hospitalization, and at scheduled outpatient visits. Findings to Date: From January 2005 to June 2021, 5037 patients were eligible for research in TROLL. Median age was 67 years (interquartile range, 55-77), and 2622 (52.1%) were male. Of these, 2736 (54.3%) had pulmonary embolism (PE), 2034 (40.4%) had deep vein thrombosis (DVT), and 265 (5.3%) had upper-extremity DVT or splanchnic or cerebral sinus vein thrombosis. In total, 2330 (46.3%) were classified as unprovoked VTE, and 1131 (22.5%) had cancer. Direct oral anticoagulants were the most frequent therapeutic agents (39.3%) followed by low-molecular-weight heparins (30.4%) and vitamin K antagonists (30.3%). Outpatient treatment for PE increased from 4% in 2005 to 23% in 2019. Future Plans: TROLL is a population-based ongoing registry that represents a valuable source of real-world data that will be used for future research on the management and outcomes of VTE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.